Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04310930Phase 2Recruiting

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Role: collaborator

NCT03214822Not ApplicableCompleted

Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants

Role: collaborator

NCT02153736Not ApplicableCompleted

Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention

Role: collaborator

NCT02086851Not ApplicableCompleted

Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program.

Role: collaborator

All 4 trials loaded